A 24-week clinical trial shows how combining a low-energy diet with structured exercise drove fat loss and remission in early-onset type 2 diabetes.
Between September 28 and October 2, 2026, researchers presented the RESET for Remission trial findings at the European Association for the Study of Diabetes annual meeting in Milan. News-Medical reported these details as published in The Lancet Regional Health Americas. The trial tested a highly structured lifestyle program for a specific clinical population. It enrolled 96 adults aged 18 to 45 who were living with obesity and early-onset type 2 diabetes. Crucially, none of these participants were using insulin therapy at the time of the study.
The trial was conducted as a randomized, open-label, blinded-endpoint study across three centers in England and Canada. Participants were randomly assigned to either receive usual care or join the lifestyle intervention group. The program sought to measure how dietary changes combined with structured physical activity affect diabetes remission. Investigators Kaberi Dasgupta of McGill University and Thomas Yates of the University of Leicester were named in the report. Their work highlights the ongoing medical interest in lifestyle approaches for metabolic conditions.
The study structure required significant time and commitment from the intervention group. Participants adhered to a closely monitored protocol that phased through different stages of restriction and maintenance. By running the trial over 24 weeks, researchers could observe both the initial weight loss phase and a subsequent maintenance period. This design helps establish a clearer timeline for how the body responds to sudden energy deficits. The resulting data provides a detailed look at short-term clinical outcomes for early-onset type 2 diabetes.
The intervention used a bundled approach to drive rapid metabolic changes. During the first 12 weeks, participants followed a low-energy diet providing just 800 to 900 kcal per day. This dietary phase was paired with supervised aerobic and resistance exercise sessions twice a week. Participants also completed one independent exercise session each week during this period. The strict energy restriction was intended to force the body to use stored energy rapidly.
In weeks 13 through 24, the program shifted from active weight loss to a maintenance phase. Participants transitioned to a weight-maintenance diet while continuing their independent exercise sessions. The supervised workouts were removed to test the transition toward more self-managed physical activity. The researchers stated that resistance training specifically targeted muscle during the intensive weight loss phase. They noted that preserving muscle may matter significantly for long-term metabolic health and physical function.
When caloric intake drops drastically, the body often loses fat-free mass alongside body fat. This loss of muscle tissue can lower the metabolic rate and negatively impact how the body processes nutrients. Incorporating regular strength training sends a biological signal to the body to retain its muscle tissue. For everyday adults, understanding how structured movement supports body composition is a vital part of sustainable weight management. Maintaining muscle helps ensure that the weight lost comes primarily from fat stores.
By aiming to preserve muscle mass, the intervention sought to improve overall metabolic function. The researchers reported improvements in muscle quality, function and cardiovascular health throughout the trial. Healthy muscle tissue acts as a primary disposal site for circulating blood glucose. Stronger and more active muscles improve how effectively the body clears glucose from the bloodstream. This physiological response is incredibly important for individuals managing blood sugar issues and insulin resistance.
Mainstream headlines often latch onto high success rates without providing the full clinical context. The news report indicates that 54 percent of intervention participants met the remission criteria at 24 weeks. Remission was defined strictly as an HbA1c below 6.5 percent without glucose-lowering medication for at least 12 weeks. While promising, this figure applies exclusively to adults aged 18 to 45 with early-onset type 2 diabetes. It should not be assumed to establish the exact same outcomes for older adults or those without diabetes.
This program is not a universal prescription for the general public. The 800 to 900 kcal per day diet was a medically managed trial intervention rather than a standard consumer diet. The report details medication changes at the initiation of the diet, underscoring the absolute necessity of clinical supervision. Readers should view this as a medical treatment tested in a clinical setting. It is not a template for everyday adults seeking standard weight management without professional oversight.
Furthermore, the intervention was a bundled program consisting of caloric restriction, supervised workouts and an independent maintenance phase. Because of this bundled design, the outcomes do not isolate the separate contributions of diet and exercise. The trial simply shows what happened when these specific elements were combined in a highly controlled environment. Anyone looking to understand how blood sugar responds to lifestyle adjustments should consult their physician before changing their routine.
Finally, the safety profile requires careful reading and consideration. The news report notes that 43 of 50 intervention participants experienced adverse events during the trial. In contrast, only 6 of 46 control participants reported similar adverse events. These effects were mainly early symptoms like constipation, headache, dizziness and fatigue. While the report says these side effects eventually resolved, they highlight the physical toll of aggressive energy restriction.
The 24-week data provides specific insights into how the participants physically responded to the bundled intervention. In the intervention group, 27 of 50 participants achieved the stated remission outcome. In the usual-care group, only 2 of 46 participants met this same criteria, representing just 4 percent. The investigators characterized their 54 percent remission rate as being at the upper end of rates reported in similar trials. However, the news report does not provide the underlying comparison table to verify that assessment.
Weight reduction was another primary outcome measured closely at the end of the 24-week period. The intervention group lost an average of 8.4 kg overall. Meanwhile, the participants receiving usual care lost an average of just 1.2 kg. The adjusted difference between the two groups was recorded as 7.5 kg. This substantial gap illustrates the immediate impact of the low-energy diet when combined with regular physical activity.
The composition of that lost weight is particularly significant for assessing long-term metabolic health. The adjusted difference included 6.6 kg more fat mass lost in the intervention group compared to the usual care group. This specific data point highlights how the structured program successfully targeted body fat rather than just overall scale weight. Although muscle preservation was reported as an outcome, the news article did not provide numerical results for it. The lack of specific muscle data in the report limits our ability to quantify the exact preservation rate.
The improvements in cardiovascular health and muscle function were noted as positive secondary outcomes by the researchers. However, the absence of hard numbers for these metrics means readers must interpret the claims cautiously. Clinical trials often measure these functional outcomes using specialized fitness tests and body composition scans. Without the raw data, we can only acknowledge that the investigators observed positive functional trends alongside the fat loss.
The findings from the RESET for Remission trial offer valuable but decidedly short-term clinical insights. Because outcomes were only assessed at 24 weeks, the durability of these metabolic results remains entirely unknown. The investigators explicitly called for longer-term evaluation to see if the remission and muscle-related benefits actually persist. Real-world settings often present behavioral and adherence challenges that closely supervised clinical trials completely avoid. Future studies must determine if these intense lifestyle changes can be maintained outside a laboratory environment.
Weight regain is a well-documented risk following intense low-energy dietary interventions. The trial report raises the valid possibility that future weight regain may disproportionately restore fat rather than fat-free mass. This physiological reality underscores the need to build resilient daily habits that can outlast a short-term clinical program. Understanding how to manage long-term weight maintenance is just as critical as navigating the initial weight loss phase. Without a sustainable exit strategy, the benefits of rapid weight loss can quickly disappear.
Future research will need to isolate which components of this bundled intervention drive the most metabolic benefit. Scientists must determine if the expensive supervised exercise sessions are strictly necessary to achieve these remission rates. They also need to test how older adults or individuals with different clinical profiles might respond to the same protocol. Until those longer-term studies are published, this trial stands as a compelling look at intensive lifestyle management.
The medical community will be watching to see if these participants can maintain their remission over multiple years. Observing how their body composition changes over time will provide better answers regarding muscle preservation. Until then, WeightRestart remains committed to translating these clinical updates into realistic context. We will continue to monitor the evidence surrounding diet, exercise and metabolic health.
WeightRestart shares research-led guidance on weight loss, metabolism, nutrition, strength, appetite, sleep and recovery. Our goal is to make complex health information clear, practical and useful for people building progress they can maintain.
Learn how to build a weight-management approach around better information, realistic expectations and habits you can keep using.
read the blog
